Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Vash2 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Neu2 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Plcd4 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Mef2c - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
GEO DataSets Profile neighbors
Tmod1 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Ky - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Aimp2 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Rragd - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Mss51 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Cib2 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Cacna2d1 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Smarcd3 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Cfl2 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Fyco1 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Jph1 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Tfdp1 - Peroxisome proliferator-activated receptor-γ ligand treatment: adipose tissue, skeletal muscle, and liver
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on